# CNS Pharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [CNS Pharmaceuticals, Inc.](/companies/cnsp.md) (CIK 1729427)
- Form: 10-K/A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 20:30 ET
- Period: 2025-12-31
- Accession: 0001683168-26-003374
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729427/000168316826003374/cns_i10ka1-123125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729427/000168316826003374/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1729427/000168316826003374/cns_i10ka1-123125.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-003374. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.